Advertisement
Advertisement
IGM Biosciences Inc. (US4495851085.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Follow
At close: 05:41PM CET
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 19.80 |
| Open | 19.80 |
| Bid | 20.60 x N/A |
| Ask | 21.20 x N/A |
| Day's Range | 19.80 - 20.60 |
| 52 Week Range | 19.80 - 20.60 |
| Volume | |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
The Independent Director of IGM Biosciences, Inc. (NASDAQ:IGMS), M. Behrens, Just Bought 27% More Shares
Those following along with IGM Biosciences, Inc. ( NASDAQ:IGMS ) will no doubt be intrigued by the recent purchase of...
- Zacks
IGM Biosciences, Inc. (IGMS) Reports Q3 Loss, Lags Revenue Estimates
IGM Biosciences, Inc. (IGMS) delivered earnings and revenue surprises of 8.97% and 15.13%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Here's Why We're Not At All Concerned With IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
